TNFRSF11A and inflammatory bowel disease: The RANKL/RANK/OPG (Receptor Activator for Nuclear Factor κ B Ligand/Receptor Activator of Nuclear Factor κ B/Osteoprotegerin) pathway plays an important role in bone turnover, and it is activated by excessive inflammation in IBD [37].